{"id":2967,"date":"2026-08-26T11:48:32","date_gmt":"2026-08-26T10:48:32","guid":{"rendered":"https:\/\/officialcorepeptides.brandloom.net\/en\/?post_type=product&p=2967"},"modified":"2026-08-26T11:48:32","modified_gmt":"2026-08-26T10:48:32","slug":"buy-syn-coll-in-switzerland","status":"publish","type":"product","link":"https:\/\/officialcorepeptides.ch\/en\/product\/buy-syn-coll-in-switzerland\/","title":{"rendered":"Syn-Coll (Palmitoyl Tripeptide-5) (200MG)"},"content":{"rendered":"

What Is Syn-Coll?<\/h2>\n

Syn-Coll, also known as Palmitoyl Tripeptide-5, is a synthetic palmitoylated tripeptide with the amino acid sequence Pal-Lys-Val-Lys-OH (Pal-KVK). It belongs to a class of biomimetic lipopeptides developed to replicate the biological activity of thrombospondin-1 (TSP-1), a large multifunctional glycoprotein (~450 kDa) that plays a critical role in activating latent transforming growth factor-\u03b2 (TGF-\u03b2) in the extracellular space. For those looking to buy Syn-Coll in Switzerland<\/strong>, Core Peptides offers high-quality research-grade material for laboratory applications.<\/p>\n

As a tripeptide\u2014a peptide composed of three amino acids\u2014Syn-Coll features N-terminal palmitoylation, which enhances its lipophilicity and facilitates transport through lipid-rich barriers. The palmitoyl moiety serves a dual purpose: it increases skin penetration by enhancing lipophilicity and anchors the peptide in cell membranes, prolonging its local activity. The peptide is commonly supplied as the bistrifluoroacetate salt with the molecular formula C33H65N5O5\u00b72(C2HF3O2) and a molecular weight of approximately 839.96 g\/mol. Its INCI name is Palmitoyl Tripeptide-5, and it is identified by CAS number 623172-56-5.<\/p>\n

Syn-Coll Research Overview<\/h2>\n

Syn-Coll has attracted research interest as a tool for investigating TGF-\u03b2 signaling, fibroblast biology, and extracellular matrix remodeling. The peptide’s design\u2014a palmitoylated tripeptide mimicking the active region of thrombospondin-1\u2014enables it to activate latent TGF-\u03b2 and stimulate collagen synthesis in dermal fibroblasts. Developed by DSM under the SYN-COLL brand name, it captures the key TGF-\u03b2-activating sequence in a small, cell-permeable format.<\/p>\n

Research interest in Syn-Coll centers on its ability to activate the TGF-\u03b2 signaling pathway, a primary driver of collagen synthesis. Studies have demonstrated that Palmitoyl Tripeptide-5 stimulates procollagen I synthesis in a dose-dependent manner, with reported increases of up to 119% compared to untreated controls at concentrations achievable through topical application. Consequently, Syn-Coll has generated interest as a research tool for investigating fibroblast activation, collagen biosynthesis, extracellular matrix remodeling, and TGF-\u03b2 pathway biology.<\/p>\n

When researchers choose to buy Syn-Coll in Switzerland<\/strong> for laboratory studies, they gain access to a compound that may help elucidate mechanisms of TGF-\u03b2 signaling, collagen regulation, and fibroblast function at the molecular level.<\/p>\n

How Does Syn-Coll Work?<\/h2>\n

Syn-Coll exerts its biological effects through activation of the TGF-\u03b2 signaling pathway, mimicking the action of thrombospondin-1 (TSP-1). The peptide’s mechanism involves several well-characterized steps.<\/p>\n

Thrombospondin-1 Mimicry and Latent TGF-\u03b2 Activation<\/h3>\n

Syn-Coll mimics the KRFK sequence region of thrombospondin-1 responsible for activating latent TGF-\u03b2. In the extracellular matrix, TGF-\u03b2 is secreted as a latent complex bound to the latency-associated peptide (LAP). TSP-1\u2014and by extension its mimetic peptide\u2014interacts with LAP to release active TGF-\u03b2. The specific amino acid sequence Lys-Val-Lys was identified as a key motif for this activity.<\/p>\n

Once liberated, active TGF-\u03b2 binds to type II TGF-\u03b2 receptors on fibroblast surfaces, initiating phosphorylation of Smad2\/Smad3 transcription factors. The activated Smad complex then translocates to the nucleus, where it upregulates transcription of procollagen I\u2014the precursor to the most abundant dermal collagen\u2014as well as tissue inhibitors of metalloproteinases (TIMPs) and other extracellular matrix glycoproteins.<\/p>\n

Collagen Synthesis Stimulation<\/h3>\n

This signaling cascade triggers fibroblasts to increase the synthesis of extracellular matrix components, most notably collagen types I and III. In vitro studies on human dermal fibroblasts have demonstrated that Palmitoyl Tripeptide-5 stimulates procollagen I synthesis in a dose-dependent manner. The peptide stimulates the production of type I and type III collagen by dermal fibroblasts.<\/p>\n

MMP Inhibition and Collagen Preservation<\/h3>\n

In addition to stimulating collagen synthesis, Syn-Coll inhibits the activity of matrix metalloproteinases (MMPs) responsible for collagen degradation. The peptide interferes with the degradation of MMP-1 and MMP-3 collagen to enhance collagen synthesis and reduce collagen breakdown. Furthermore, the upregulation of TIMPs reduces MMP-mediated collagen degradation.<\/p>\n

This dual-action mechanism\u2014promoting collagen synthesis while reducing degradation\u2014distinguishes the TSP-1 mimetic approach from simple signal peptides.<\/p>\n

Researchers who buy Syn-Coll in Switzerland<\/strong> for research purposes can investigate these mechanisms across diverse experimental models of fibroblast biology, TGF-\u03b2 signaling, and extracellular matrix remodeling.<\/p>\n

Why Is Syn-Coll Studied?<\/h2>\n

Researchers study Syn-Coll primarily for its potential relevance to TGF-\u03b2 signaling, fibroblast biology, and extracellular matrix remodeling. The peptide’s ability to activate latent TGF-\u03b2 and stimulate collagen synthesis makes it a valuable tool for understanding the molecular basis of connective tissue maintenance and repair.<\/p>\n

Syn-Coll’s connection to the thrombospondin-1\/TGF-\u03b2 axis has made it a focus of dermal and matrix biology research. Preclinical studies have explored Syn-Coll’s effects on collagen biosynthesis, fibroblast proliferation, and matrix organization in various experimental models.<\/p>\n

Moreover, researchers study Syn-Coll in the context of extracellular matrix homeostasis and age-related matrix changes. In vitro studies have demonstrated that the peptide’s effects are mediated through TGF-\u03b2 pathway activation; neutralizing antibodies against TGF-\u03b2 abolish the procollagen-stimulating effect of the peptide in fibroblast cultures, confirming the TSP-1 mimetic mechanism.<\/p>\n

Researchers who buy Syn-Coll in Switzerland<\/strong> from Core Peptides can incorporate this peptide into their studies on TGF-\u03b2 signaling, fibroblast activation, collagen synthesis, and extracellular matrix biology.<\/p>\n

Syn-Coll Research Areas<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n
Research Area<\/th>\nDescription<\/th>\n<\/tr>\n<\/thead>\n
TGF-\u03b2 Signaling<\/strong><\/td>\nInvestigating Syn-Coll’s activation of latent TGF-\u03b2 and downstream Smad2\/Smad3 signaling<\/td>\n<\/tr>\n
Collagen Synthesis<\/strong><\/td>\nStudying Syn-Coll’s stimulation of procollagen I and III production in fibroblasts<\/td>\n<\/tr>\n
Fibroblast Activation<\/strong><\/td>\nExamining Syn-Coll’s effects on fibroblast proliferation and extracellular matrix production<\/td>\n<\/tr>\n
Extracellular Matrix Remodeling<\/strong><\/td>\nExploring Syn-Coll’s influence on ECM composition and structural integrity<\/td>\n<\/tr>\n
MMP Inhibition<\/strong><\/td>\nInvestigating Syn-Coll’s effects on matrix metalloproteinase activity and collagen degradation<\/td>\n<\/tr>\n
Thrombospondin-1 Mimicry<\/strong><\/td>\nStudying Syn-Coll as a biomimetic of TSP-1 for latent TGF-\u03b2 activation<\/td>\n<\/tr>\n
Dermal Fibroblast Research<\/strong><\/td>\nPreclinical research into Syn-Coll’s effects on dermal fibroblast function<\/td>\n<\/tr>\n
Connective Tissue Biology<\/strong><\/td>\nExploring Syn-Coll’s potential relevance to connective tissue maintenance and repair<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Scientific Research on Syn-Coll<\/h2>\n

Researchers have conducted scientific studies on Syn-Coll in both in vitro and clinical settings, deriving evidence from cell cultures, preclinical models, and human studies. The peptide originates from thrombospondin-1 mimetic research and was developed by DSM under the SYN-COLL brand name.<\/p>\n

In Vitro Evidence<\/h3>\n

In vitro studies using human dermal fibroblasts have demonstrated that Palmitoyl Tripeptide-5 stimulates procollagen I synthesis in a dose-dependent manner. At concentrations achievable through topical application, the peptide increased procollagen production by up to 119% compared to untreated controls.<\/p>\n

Mechanistic studies confirmed that the anti-aging effects of Palmitoyl Tripeptide-5 are mediated through TGF-\u03b2 pathway activation. For instance, neutralizing antibodies against TGF-\u03b2 abolished the procollagen-stimulating effect of the peptide in fibroblast cultures, confirming the TSP-1 mimetic mechanism rather than a nonspecific mitogenic effect.<\/p>\n

Furthermore, Syn-Coll has been shown to stimulate the production of type I and type III collagen by dermal fibroblasts while interfering with the degradation of MMP-1 and MMP-3 collagen, thereby enhancing collagen synthesis and reducing collagen breakdown. The peptide effectively signals fibroblasts to increase the production of collagen types I and III.<\/p>\n

Clinical Studies<\/h3>\n

Double-blind, placebo-controlled clinical studies evaluating SYN-COLL at 4 ppm in a cream base applied twice daily for 84 days demonstrated significant improvements in wrinkle parameters. Profilometric analysis showed reductions in wrinkle depth and volume, with visible improvements noted by expert graders and self-assessment panels. The effect was progressive, with continued improvement observed through the study duration.<\/p>\n

Additionally, clinical studies by DSM showed that 4% SYN-COLL cream reduced wrinkle depth by up to 35% and increased skin firmness by 25% after 84 days of use.<\/p>\n

Transdermal Research<\/h3>\n

Research has also explored the transdermal permeation of Palmitoyl Tripeptide-5. A 2023 study investigated the delivery of active peptides by self-healing, biocompatible supramolecular hydrogels, analyzing the transdermal permeation of Palmitoyl Tripeptide-5 using Franz diffusion cells. The study found that almost no transdermal permeation of Palmitoyl Tripeptide-5 was observed, consistent with its lipophilic nature and intended topical application.<\/p>\n

Nevertheless, researchers should note that Syn-Coll is supplied for laboratory research purposes only. Scientists who buy Syn-Coll in Switzerland<\/strong> should remain aware of these evidence considerations.<\/p>\n

Syn-Coll Compared With Related Peptides<\/h2>\n\n\n\n\n\n\n\n\n\n
Peptide<\/th>\nRelationship to Syn-Coll<\/th>\nKey Differences<\/th>\n<\/tr>\n<\/thead>\n
Palmitoyl Tripeptide-1 (Pal-GHK)<\/strong><\/td>\nBoth are palmitoylated tripeptides<\/td>\nSyn-Coll targets TGF-\u03b2 via TSP-1 mimicry; Pal-GHK is a matrikine peptide with different signaling mechanism<\/td>\n<\/tr>\n
Palmitoyl Pentapeptide-4 (Matrixyl)<\/strong><\/td>\nBoth studied for collagen stimulation<\/td>\nSyn-Coll acts via TGF-\u03b2 pathway activation; Matrixyl acts via collagen fragment signaling<\/td>\n<\/tr>\n
Thrombospondin-1 (TSP-1)<\/strong><\/td>\nNatural protein; Syn-Coll is a synthetic mimetic<\/td>\nTSP-1 is a ~450 kDa glycoprotein; Syn-Coll is a small tripeptide capturing the key active sequence<\/td>\n<\/tr>\n
Palmitoyl Tetrapeptide-7<\/strong><\/td>\nBoth are palmitoylated peptides for skin research<\/td>\nPalmitoyl Tetrapeptide-7 targets IL-6 and inflammation; Syn-Coll targets TGF-\u03b2 and collagen synthesis<\/td>\n<\/tr>\n
GHK-Cu<\/strong><\/td>\nBoth studied for skin and cellular research<\/td>\nGHK-Cu is a copper complex with different mechanism; Syn-Coll is a TSP-1 mimetic activating TGF-\u03b2<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Research Applications<\/h2>\n

Researchers utilize Syn-Coll in a variety of laboratory research applications, primarily in the fields of cell biology, dermatology, and extracellular matrix research. Key research applications include:<\/p>\n